AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimwalf-M2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Walfs Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimwalf-M2 Tablet SR

Diabex Duo SR tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose (e.g., sugary snacks or juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Glimwalf-M2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimwalf-M2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Glimwalf-M2 Tablet SR with a meal.

Common Side effects of Glimwalf-M2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimwalf-M2 Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimwalf-M2 Tablet SR with a meal.

How Glimwalf-M2 Tablet SR works:

Glimwalf-M2 SR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreased hepatic glucose production, reduced intestinal glucose uptake, and improved insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimwalf-M2 Tablet SR and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimwalf-M2 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimwalf-M2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is a possibility with either hypo- or hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimwalf-M2 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimwalf-M2 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. In patients exhibiting mild to moderate liver dysfunction, Glimwalf-M2 Tablet SR therapy should commence with a reduced initial dose; its use is contraindicated in cases of severe liver disease.

What if you forget to take Glimwalf-M2 Tablet SR :

Should you forget a Glimwalf-M2 Tablet SR dose, take it immediately if you remember. However, near your next scheduled dose, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Glimwalf-M2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimwalf-M2 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Glimwalf-M2 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimwalf-M2 Tablet SR and seek immediate medical attention.
Glimwalf-M2 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimwalf-M2 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimwalf-M2 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Glimwalf-M2 SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimwalf-M2 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and increase the risk of lactic acidosis.
Glimwalf-M2 Tablet SR
70
MRP 81
13% off